Search
for
Sort by
Research 331–360 of 1000+
- Subject Index
- Nails and hair
- Clinical Management in Psychodermatology
- American Academy of Dermatology
- Common Dermatologic Conditions
- Efficacy and safety of a new formulation kit (shampoo + lotion) containing anti‐inflammatory and antioxidant agents to treat hair loss
- Lab Quality Management and Methodology
- Dermatologic therapy: December 1987 to December 1988
- Dermatologic therapy: December 1986 to December 1987
- Tinea Capitis: An Overview with Emphasis on Management
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Retinoids in Dermatology
- Culprits of Medication-Induced Telogen Effluvium, Part 1
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Response to Mounessa et al.’s “Commonly prescribed medications associated with alopecia’’
- Quality of Life Assessment in Male Patients with Androgenetic Alopecia: Result of a Prospective, Multicenter Study
- Management of tinea capitis in childhood
- Granzyme B in Autoimmune Skin Disease
- Blue Light in Dermatology
- The Contributory Roles of Th17 Lymphocyte and Cytotoxic T Lymphocyte at the Hair Bulge Region as Well as the Hair Bulb Area in the Chronic Alopecia Areata Patients
- Metabolic syndrome in androgenic alopecia
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Home Remedies in Dermatology
- Efficacy, safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study
- Microneedling for Cutaneous Manifestations of Autoimmune Disease: A Scoping Review
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
- Evaluation of NF-κB as a Novel Serum Biomarker in Androgenetic Alopecia Patients: A Case–Control Study